Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

By LabMedica International staff writers
Posted on 26 Apr 2024

The process of biopsy is important for confirming the presence of cancer. More...

In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope to identify cancerous markers. This lengthy procedure often results in patients waiting weeks or months for their results, causing treatment delays and heightened anxiety. Now, a breakthrough digital medical imaging system promises to transform cancer detection by offering instantaneous results, facilitating timely and effective treatment across all cancer types.

The Photon Absorption Remote Sensing (PARS) system, an innovative, built-from-scratch technology developed by researchers at the University of Waterloo (Ontario, Canada), marks a radical departure from traditional cancer detection methods, promising diagnoses within minutes and enabling rapid surgical intervention. The system utilizes lasers to irradiate tissue samples, producing a comprehensive, high-resolution data set. This data is then processed by an artificial intelligence (AI) system that converts it into a conventional histopathology image for pathologist review. This innovative approach eliminates the need for multiple slide preparations by using digital image filters on a single tissue sample, allowing multiple reads without damaging the tissue, thus preserving it for further necessary analyses.

By substituting traditional procedures with this advanced, AI-driven high-resolution imaging, the PARS system drastically cuts down diagnostic times, conserving time and resources. It has proven highly precise in clinical trials involving human breast tissue; pathologists found no distinguishable differences between images produced by the PARS system and those obtained through traditional methods. The technology demonstrated a 98% accuracy rate in line with established diagnostic techniques.

“This invention will transform digital pathology, enabling surgeons to obtain multiple results simultaneously with just one biopsy and provide accurate diagnoses within minutes,” said Dr. Parsin Haji Reza, lead researcher and a professor in Waterloo’s Department of Systems Design Engineering. “It also ensures thorough removal of cancerous tissue before closing the incision, mitigating the need for further surgeries.”

Related Links:
University of Waterloo


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Senior researcher Annikka Polster collaborated with Nicola Pietro Montaldo in discovering the Parkinson’s Biomarkers (Photo courtesy of Chalmers University of Technology)

Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests

Parkinson’s disease is a slow-progressing neurological disorder that disrupts the brain’s ability to control movement and is typically diagnosed after the age of 55. By the time motor symptoms appear,... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Noul’s AI-based cervical cancer diagnostic solution, miLab CER (Photo courtesy of Noul)

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.